HealthPhoto: The Clinical Trial VanguardKos Biotechnology Funds Golden Age Health for Rare Disease Access in Asia
Kos Biotechnology Partners has invested in Golden Age Health to speed up access to rare disease treatments in Asia. This funding aims to reduce treatment delays for patients in Greater China and Southeast Asia, improving healthcare outcomes for those affected by rare diseases in the region.
The Clinical Trial Vanguard·


